Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425094 · ClinicalTrials.gov registry record · NA
Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT06425094: Completed NA study, sponsored by Colorado State University.
NCT06425094 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06425094, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This study will be conducted to determine the effect of daily Tetrasol consumption in supporting gut health using assessments of gastrointestinal symptoms (GSRS) and bowel habits (BSS) as primary outcome measures. The investigators also intend to explore fecal and blood biomarkers of intestinal permeability/function, determination of anxiety and stress levels through both validated assessments and saliva and blood biomarkers, establishment of intervention safety and tolerability through comprehensive metabolic panels and overall compliance, explore the effects of the intervention on inflammation and acute stress (Cold Presser Test), blood lipid profiles, and gut microbiota composition as secondary outcomes.
Primary Outcome
Product safety will be assessed using the Piccolo Xpress Comprehensive Metabolic Panel that is conducted on samples collected at visit 2 (baseline), visit 3 (Week 2) \& visit 4 (Week 4) for deviations from standard reference ranges for analytes in this panel.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Microalgae Extract Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What the finished NCT06425094 record still lists
NCT06425094 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06425094 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06425094 about?
NCT06425094 is a clinical study titled "Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function". This study will be conducted to determine the effect of daily Tetrasol consumption in supporting gut health using assessments of gastrointestinal symptoms (GSRS) and bowel habits (BSS) as primary outcome measures. The investigators also intend to explore fecal and blood biomarkers of intestinal perm...
What is the current status of trial NCT06425094?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2024-02-05. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT06425094?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Microalgae Extract Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06425094?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06425094's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI